🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, randomized, parallel group two-stage phase 1-2 study...
Status
Unknown
Location
Inst of Cancer Research & Royal Marsden NHS Foundation Trust
Start Date
2014-02
Trial ID
NCT02049190
Treatments Being Tested
The researchers are doing this study to find out whether the study drug ona...
Status
Withdrawn
Location
Memorial Sloan Kettering Westchester (All Protocol Activities)
Start Date
2021-09-09
Trial ID
NCT04872608
Treatments Being Tested
This is a multi-center, open-label, randomized, parallel group two-stage ph...
Status
Unknown
Location
Centre Oscar Lambret
Start Date
2014-01
Trial ID
NCT02052128
Treatments Being Tested
ONAWA is a window of opportunity, prospective, multicenter, phase 0 trial w...
Status
Completed
Location
Hospital Universitari Vall d'Hebron
Start Date
2020-11-06
Trial ID
NCT04142892
Treatments Being Tested
This phase II trial studies the effect of onapristone and anastrozole in tr...
Status
Completed
Location
Jefferson Abington Hospital
Start Date
2021-01-28
Trial ID
NCT04719273
Treatments Being Tested
The purpose of this study is to test any good and bad effect of the study d...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge
Start Date
2019-05-02
Trial ID
NCT03909152
Treatments Being Tested
This is a multicenter, Phase 1b-2 study of elacestrant in combination with ...
Status
Terminated
Location
Cancer Treatment Centers of America - Western Regional Medical Center
Start Date
2022-12-02
Trial ID
NCT05618613
Treatments Being Tested
This is a rollover study for patients enrolled in the discontinued ELONA cl...
Status
Withdrawn
Location
Sarah Cannon Research Institute
Start Date
2023-06
Trial ID
NCT06938711
Treatments Being Tested
A phase II single-arm trial of onapristone in combination with fulvestrant ...
Status
Terminated
Location
University of Wisconsin Carbone Cancer Center
Start Date
2021-10-05
Trial ID
NCT04738292
Treatments Being Tested